MANGALAM.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 01:03):

Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications...

Stats
Today's Volume	2 925.00
Average Volume	102 586
Market Cap	1.56B
EPS	INR0 ( 2024-02-13 )
Last Dividend	INR0.500 ( 2017-12-21 )
Next Dividend	INR0 ( N/A )
P/E	-13.78
ATR14	INR0.281 (0.28%)

Volume Correlation

Long: -0.10 (neutral)

Short: 0.53 (weak)

Signal:(50.785) Neutral

Mangalam Drugs & Organics Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Mangalam Drugs & Organics Correlation - Currency/Commodity

-0.27
( neutral )

0.17
( neutral )

0.00
( neutral )

0.31
( neutral )

0.08
( neutral )

0.29
( neutral )

Mangalam Drugs & Organics Financials

Annual	2022
Revenue:	INR3.70B
Gross Profit:	INR1.20B (32.29 %)
EPS:	INR0.800

FY	2022
Revenue:	INR3.70B
Gross Profit:	INR1.20B (32.29 %)
EPS:	INR0.800

FY	2022
Revenue:	INR4.47B
Gross Profit:	INR1.36B (30.44 %)
EPS:	INR12.42

FY	2021
Revenue:	INR3.80B
Gross Profit:	INR1.24B (32.66 %)
EPS:	INR17.67

Financial Reports:

No articles found.

Mangalam Drugs & Organics Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Mangalam Drugs & Organics Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 2.16 - No dividend growth expected in the near future

Information

First Dividend	INR0.200	2005-08-30
Last Dividend	INR0.500	2017-12-21
Next Dividend	INR0	N/A
Payout Date	2017-12-29
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR2.90	--
Avg. Dividend % Per Year	0.00%	--
Score	0.48	--
Div. Sustainability Score	0
Div.Growth Potential Score	2.16
Div. Directional Score	0.785	--

Next Divdend (Est)
(2024-09-26)

INR0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.48

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RAILTEL.NS	Dividend Junior	2023-08-24	Semi-Annually	4	1.19%
KHAICHEM.NS	No Dividend Player	2023-07-21	Annually	5	0.32%
EMAMIPAP.NS	Dividend Junior	2023-09-05	Annually	3	0.56%
AJANTPHARM.NS	Dividend Knight	2023-08-04	Annually	23	0.57%
SUPRAJIT.NS	Dividend Junior	2023-09-18	Semi-Annually	20	0.45%
NAVNETEDUL.NS	Dividend Junior	2023-08-07	Annually	22	1.10%
HPIL.NS	Dividend Junior	2023-09-29	Annually	5	0.89%
CARERATING.NS	Dividend Knight	2023-07-06	Semi-Annually	12	1.81%
ROUTE.NS	Dividend Junior	2023-09-06	Semi-Annually	4	0.38%
LFIC.NS	Dividend Junior	2023-08-01	Annually	15	1.73%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0473	1.500	-0.945	-1.418	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.119	1.500	-2.44	-3.66	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	-0.541	1.000	-1.312	-1.312	[3 - 30]
operatingCashFlowPerShareTTM	17.10	2.00	4.30	8.60	[0 - 30]
freeCashFlowPerShareTTM	17.10	2.00	1.448	2.90	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.286	1.000	8.57	8.57	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0202	1.000	-2.40	-2.40	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.593

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-9.17	1.000	-1.027	0	[1 - 100]
returnOnEquityTTM	-0.119	2.50	-1.568	-3.66	[0.1 - 1.5]
freeCashFlowPerShareTTM	17.10	2.00	4.30	2.90	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	17.10	2.00	4.30	8.60	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.860	1.500	7.60	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0753	1.000	-0.617	0	[0.1 - 0.5]
Total Score				2.16

Mangalam Drugs & Organics